Cantor Fitzgerald Reiterates Overweight Rating on Cartesian Therapeutics (RNAC)
Go back to Cantor Fitzgerald Reiterates Overweight Rating on Cartesian Therapeutics (RNAC)| (NASDAQ: RNAC) | Delayed: 7.92 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.92 | 52 Week High | $ | |||
| Open | $7.92 | 52 Week Low | $ | |||
| Day High | $7.92 | P/E | N/A | |||
| Day Low | $7.92 | EPS | $ | |||
| Volume | 3 | |||||
